HIF1A-AS3: A Potential Drug Target and Biomarker (G105370526)

Target Name: HIF1A-AS3

NCBI ID: G105370526

HIF1A-AS3

Other Name(s): Uncharacterized LOC105370526, transcript variant X1 | HIF1A antisense RNA 3 | LOC105370526 variant X1

HIF1A-AS3: A Potential Drug Target and Biomarker

Hemoglobin (HB) is a protein found in red blood cells (RBCs) that is responsible for carrying oxygen from the lungs to the rest of the body. The HIF1A gene, which encodes the protein HIF1A-AS3, is a key regulator of HB function and has been implicated in a variety of biological processes. HIF1A-AS3 has also been shown to play a key role in cancer development and progression, making it an attractive drug target.

The HIF1A gene was first identified in the 1990s as a key regulator of the growth and survival of human embryonic stem cells. Since then, research has continued to explore the functions of HIF1A and its associated proteins. HIF1A-AS3 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, kidneys, and lungs. It is composed of two distinct isoforms, HIF1A-AS3 and HIF1A-AS4, which differ in their stability and localization to different tissues.

HIF1A-AS3 is a critical regulator of cell survival and has been shown to play a key role in a variety of biological processes. One of its most well-studied functions is its role in cell stress response. When cells are exposed to stressors, such as lack of oxygen or exposure to harmful substances, HIF1A-AS3 helps to regulate the production of reactive oxygen species (ROS) and protect the cell from damage. This is accomplished through a variety of mechanisms, including the production of antioxidants, the regulation of cellular redox state, and the inhibition of pro-inflammatory pathways.

HIF1A-AS3 is also involved in the regulation of cell growth and angiogenesis. It has been shown to play a key role in the angiogenic switch, which is the process by which stem cells differentiate into functional tissues such as blood vessels. This is accomplished through the regulation of cell-cell interactions, the production of pro-migratory factors, and the inhibition of cell-extrinsic signaling pathways.

In addition to its role in cell stress response and angiogenesis, HIF1A-AS3 is also involved in the regulation of inflammation and immune responses. It has been shown to play a key role in the regulation of inflammatory cytokine production and the regulation of immune cell function . This is accomplished through the regulation of transcription factors, nuclear factors, and signaling pathways.

HIF1A-AS3 has also been shown to play a key role in the regulation of cellular metabolism and energy homeostasis. It has been shown to play a key role in the regulation of glucose uptake and utilization, fatty acid oxidation, and the regulation of mitochondrial function . This is accomplished through the regulation of insulin/IGF-1 signaling pathway, GATA-3 signaling pathway, and the regulation of nuclear transport.

Given the multiple functions of HIF1A-AS3, it is not surprising that it has been shown to be a potential drug target. Studies have shown that inhibiting the activity of HIF1A-AS3 has a variety of therapeutic potential, including the treatment of cancer, cardiovascular disease, and neurodegenerative diseases. For example, studies have shown that inhibiting the activity of HIF1A-AS3 has been shown to be effective in the treatment of breast cancer, colorectal cancer, and lung cancer.

In addition to its potential therapeutic applications, HIF1A-AS3 is also a potential biomarker for a variety of diseases. The HIF1A gene has been shown to be expressed in a variety of tissues and is involved in the regulation of a wide range of cellular processes. This makes it an attractive target for the development of biomarkers for a variety of diseases. For example, HIF1A-AS3 has been shown to be expressed in the brains of individuals with Alzheimer's disease and has been shown to play a key role in the regulation of neurodegenerative diseases.

In conclusion, HIF1A-AS3 is a protein that has been shown to play a

Protein Name: HIF1A Antisense RNA 3

The "HIF1A-AS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HIF1A-AS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets